⌘K
Loading ticker…
As of 2026-08-24, Ionis Pharmaceuticals, Inc. Common Stock (IONS) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.4%, relative volume 0.90×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
IONS is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -2.7% / -16.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
IONS is held by 39 ETFs as of May 2026. Top owner: CGGR at 0.36% weight, $88M notional. Top 3 carry $183M.
Held by 119 ETFs · $1.8B across latest filings · largest weight 4.73% (MEDX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| CGGR | 0.36% | $88M | −0.06 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.26% | $60M | −0.05 pp |
| VHTVanguard Health Care ETF | 0.19% | $35M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.23% | $34M | −0.03 pp |
| CGMM | 1.14% | $32M |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.18 pp |
| VONGVanguard Russell 1000 Growth ETF | 0.03% | $19M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.02% | $7M | — |
| QQQJ | 0.59% | $7M | −0.06 pp |
| ESML | 0.21% | $5M | −0.02 pp |
| VFMO | 0.21% | $4M | −0.24 pp |
Showing 10 of 39 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IONS Jan avg: 0.72% median: 3.04% win: 75% σ: 6.54% n: 4 2022-04-12 → 2026-07-31 | IONS Feb avg: -4.94% median: -5.90% win: 25% σ: 7.43% n: 4 2022-04-12 → 2026-07-31 | IONS Mar avg: -5.28% median: -5.79% win: 0% σ: 3.83% n: 4 2022-04-12 → 2026-07-31 | IONS Apr avg: -2.34% median: -1.03% win: 20% σ: 3.61% n: 5 2022-04-12 → 2026-07-31 | IONS May avg: 3.50% median: 2.33% win: 60% σ: 9.38% n: 5 2022-04-12 → 2026-07-31 | IONS Jun avg: 10.02% median: 3.65% win: 100% σ: 11.78% n: 5 2022-04-12 → 2026-07-31 | IONS Jul avg: -3.94% median: 1.46% win: 80% σ: 17.47% n: 5 2022-04-12 → 2026-07-31 | IONS Aug avg: 1.50% median: -1.80% win: 25% σ: 7.89% n: 4 2022-04-12 → 2026-07-31 (current) | IONS Sep avg: 13.53% median: 8.33% win: 75% σ: 29.18% n: 4 2022-04-12 → 2026-07-31 | IONS Oct avg: 1.73% median: -1.23% win: 25% σ: 8.07% n: 4 2022-04-12 → 2026-07-31 | IONS Nov avg: 2.11% median: 2.21% win: 50% σ: 10.90% n: 4 2022-04-12 → 2026-07-31 | IONS Dec avg: -2.92% median: -3.26% win: 25% σ: 4.07% n: 4 2022-04-12 → 2026-07-31 |